Physician profile
Iris R Mentle
NPI 1922054022
$1,836.76
in general payments reported to CMS, 2019-2025
17 companies · $90.59 in 2025
The $90.59 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $829 · 2020: $66.57 · 2021: $209 · 2022: $374 · 2023: $149 · 2024: $119 · 2025: $90.59.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $358.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $358.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $867.88 | 2019-2022 | |
| Irhythm Technologies, INC. | $193.38 | 2023-2024 | Zio Xt Patch, Zio Monitor |
| Pfizer INC. | $149.25 | 2019-2023 | |
| Janssen Pharmaceuticals, INC | $136.85 | 2019-2022 | |
| Novo Nordisk INC | $76.72 | 2024-2025 | Wegovy, Ozempic, Rybelsus |
| Amgen INC. | $74.37 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $68.24 | 2019 | |
| Sanofi-Aventis U.S. LLC | $66.67 | 2019 | |
| Impulse Dynamics (USA) INC. | $42.14 | 2024 | Optimizer |
| Amarin Pharma, INC. | $29.56 | 2019-2020 | |
| Gilead Sciences, INC. | $25.38 | 2019 | |
| Abbott Laboratories | $23.38 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $22.46 | 2019-2020 | |
| Boston Scientific Corporation | $18.42 | 2019 | |
| Kestra Medical Technology Services, INC. | $15.77 | 2025 | Assure Wcd |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $13.50 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $12.79 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Iris Mentle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.